13G Filing: JPMorgan Chase & Co and Kite Pharma Inc. (KITE)
You can access the original SEC filing by clicking here.
Kite Pharma Inc. (KITE)
Market is closed
News
- 1 - 10
- Next >>
Wildcat Capital: Drew Tarlow, Len Potter, Family Office Of The Year
Family offices are much more secretive compared to hedge funds.
This Hedge Fund's Picks Returned 52% in Q1 And You've Never Heard of It
You've probably read a million stories about how Bill Ackman's been getting creamed lately, how hedge funds continue to underperform indexes, and how redemptions continue to rock major hedge funds.
35 Fresh Stories That You Should Read To Know How The Financial Markets Are Doing Today
"U.S. stocks slipped Monday, as declining prices for industrial metals weighed on materials shares. The Dow Jones Industrial Average fell 15 points, or less than 0.1%, to 20992.
Is Kite Pharma Inc (KITE) a Good Stock to Buy?
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
5 Medical Tech Stocks You Should Be Investing In
The medical sector is growing rapidly and getting in on the ground floor with med tech can be highly profitable for smart investors, but how can you know which stocks to choose? In many cases, the best...
Today's Movers And Shakers In Biotech: Arrowhead Pharmaceuticals Inc (ARWR) And Kite Pharma Inc (KITE)
One thing in particular pushed the sector higher today, and so before we get going on the specific entities, it’s worth addressing. Specifically, he election of Donald Trump to the White House.
Why Kite Pharma, Rice Energy, BlackBerry, and More Are Trending
On the second day of the week, crude traders are eagerly anticipating today's API release and the latest word from the informal OPEC/Russia meeting in Algeria.
Juno Therapeutics, Kite Pharma, & Petrobras Among the Morning's Trending Stocks
Crude futures are 1% lower today after yesterday's disappointing API inventory data.
Movers And Shakers In Biotech: Kite Pharma Inc (KITE) And Eleven Biotherapeutics Inc (EBIO)
It’s been a busy week in biotech so far, and the late start out of the US doesn’t seem to have had too much of an impact on volatility.
- 1 - 10
- Next >>
Billionaire Hedge Funds
